Neurological Biomarkers Market Share, Size, and Outlook by 2031
Neurological Biomarkers Market: Strategic Insights
Neurological Biomarkers Market
-
CAGR (2023 - 2031)13.6% -
Market Size 2021
US$ 5400.90 Million -
Market Size 2031
US$ 18600.93 Million
Market Dynamics
GROWTH DRIVERS
- Rising incidences of neurological diseases
- Rapid Developments in healthcare
FUTURE TRENDS
- Advancement in biomarker discovery
- increased focus on personalized medicines
OPPORTUNITIES
- Development of novel biomarkers
- Integration of drug development and biomarkers
- Focus on early detection and prevention
Key Players
- Thermo Fisher Scientific Inc
- Abbott
- Myriad Genetics Inc
- Bio Rad Laboratories Inc
- Qiagen
- Banyan Biomarkers Inc
- Immunarray Pvt Ltd
- Quest Diagnostics Incorporated
- PerkinElmer Inc
- Merck Millipore
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product - Proteomics Biomarker
- Genomics Biomarker
- Metabolomics Biomarker
- Imaging Biomarker
Application - Alzheimer's Disease
- Parkinson's Disease
- Schizophrenia
- Huntington's Disease
- Spinal Muscular Atrophy
End User - Pharmaceutical and Biotechnology Companies
- Clinical Diagnostics
- Research Organizations
Get Free Sample For